Pain
Conference Coverage
‘Fibro-fog’ confirmed with objective ambulatory testing
MILWAUKEE – Objective smartphone-based testing tracked with subjective assessment of cognitive function in fibromyalgia.
FDA/CDC
FDA to expand opioid labeling with instructions on proper tapering
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
Conference Coverage
NIH’s HEAL initiative seeks coordinated effort to tackle pain, addiction
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
Conference Coverage
In sickle cell disease, opioid prescribing starts early, study finds
MILWAUKEE – It’s not clear what parents of children with sickle cell disease are told about when and how to administer opioid analgesia.
Conference Coverage
Addressing anxiety helps youth with functional abdominal pain disorders
MILWAUKEE – Tackling comorbid anxiety reduced pain, disability, and anxiety.
Feature
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
Conference Coverage
Opioid overdose risk greater among HIV patients
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
From the Journals
Cloud of inconsistency hangs over cannabis data
Number of medical cannabis users is up more than 10-fold since 2009, available data show.
Evidence-Based Reviews
Antidepressants for chronic pain
Certain agents may mitigate pain associated with neuropathy, fibromyalgia, headache, and IBS.
From the Journals
Age of migraine onset may affect stroke risk
One unexpected finding was that the onset of migraine with aura before age 50 is not associated with ischemic stroke.